Combination chemotherapy for metastatic or recurrent carcinoma of the breast - A randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and leukemia group B study 8281 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Neoplasm Recurrence, Local

abstract

  • The VATH regimen appears similarly effective to the CAF regimen as initial therapy. Alternating CMFVP with VATH did not improve response rate or survival. After accounting for other variables, treatment arm was not related to outcome. New therapeutic regimens are still needed.

publication date

  • June 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7751891

Additional Document Info

start page

  • 1443

end page

  • 52

volume

  • 13

number

  • 6